D Hui1, S Bansal2, F Strasser3, T Morita4, A Caraceni5, M Davis6, N Cherny7, S Kaasa8, D Currow9, A Abernethy10, C Nekolaichuk11, E Bruera2. 1. Department of Palliative Care and Rehabilitation Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: dhui@mdanderson.org. 2. Department of Palliative Care and Rehabilitation Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA. 3. Oncological Palliative Medicine, Hematology-Oncology, Cantonal Hospital, St. Gallen, Switzerland. 4. Department of Palliative and Supportive Care and Seirei Hospice, Seirei Mikatahara General Hospital, Hamamatsu, Japan. 5. Palliative Care, Pain Therapy and Rehabilitation, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. 6. Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland, USA. 7. Cancer Pain and Palliative Medicine Service, Department of Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Israel. 8. European Palliative Care Research Centre, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology and The Cancer Clinic, St. Olavs Hospital - Trondheim University Hospital, Trondheim, Norway. 9. Palliative and Supportive Services, Flinders University, Adelaide, South Australia. 10. Duke Clinical Research Institute, Duke University School of Medicine, Durham, USA. 11. Division of Palliative Care Medicine, Department of Oncology, University of Alberta, Edmonton, Canada.
Abstract
BACKGROUND: Recently, the concept of integrating oncology and palliative care has gained wide professional and scientific support; however, a global consensus on what constitutes integration is unavailable. We conducted a Delphi Survey to develop a consensus list of indicators on integration of specialty palliative care and oncology programs for advanced cancer patients in hospitals with ≥100 beds. METHODS: International experts on integration rated a list of indicators on integration over three iterative rounds under five categories: clinical structure, processes, outcomes, education, and research. Consensus was defined a priori by an agreement of ≥70%. Major criteria (i.e. most relevant and important indicators) were subsequently identified. RESULTS: Among 47 experts surveyed, 46 (98%), 45 (96%), and 45 (96%) responded over the three rounds. Nineteen (40%) were female, 24 (51%) were from North America, and 14 (30%) were from Europe. Sixteen (34%), 7 (15%), and 25 (53%) practiced palliative care, oncology, and both specialties, respectively. After three rounds of deliberation, the panelists reached consensus on 13 major and 30 minor indicators. Major indicators included two related to structure (consensus 95%-98%), four on processes (88%-98%), three on outcomes (88%-91%), and four on education (93%-100%). The major indicators were considered to be clearly stated (9.8/10), objective (9.4/10), amenable to accurate coding (9.5/10), and applicable to their own countries (9.4/10). CONCLUSIONS: Our international experts reached broad consensus on a list of indicators of integration, which may be used to identify centers with a high level of integration, and facilitate benchmarking, quality improvement, and research.
BACKGROUND: Recently, the concept of integrating oncology and palliative care has gained wide professional and scientific support; however, a global consensus on what constitutes integration is unavailable. We conducted a Delphi Survey to develop a consensus list of indicators on integration of specialty palliative care and oncology programs for advanced cancerpatients in hospitals with ≥100 beds. METHODS: International experts on integration rated a list of indicators on integration over three iterative rounds under five categories: clinical structure, processes, outcomes, education, and research. Consensus was defined a priori by an agreement of ≥70%. Major criteria (i.e. most relevant and important indicators) were subsequently identified. RESULTS: Among 47 experts surveyed, 46 (98%), 45 (96%), and 45 (96%) responded over the three rounds. Nineteen (40%) were female, 24 (51%) were from North America, and 14 (30%) were from Europe. Sixteen (34%), 7 (15%), and 25 (53%) practiced palliative care, oncology, and both specialties, respectively. After three rounds of deliberation, the panelists reached consensus on 13 major and 30 minor indicators. Major indicators included two related to structure (consensus 95%-98%), four on processes (88%-98%), three on outcomes (88%-91%), and four on education (93%-100%). The major indicators were considered to be clearly stated (9.8/10), objective (9.4/10), amenable to accurate coding (9.5/10), and applicable to their own countries (9.4/10). CONCLUSIONS: Our international experts reached broad consensus on a list of indicators of integration, which may be used to identify centers with a high level of integration, and facilitate benchmarking, quality improvement, and research.
Authors: Camilla Zimmermann; Nadia Swami; Monika Krzyzanowska; Breffni Hannon; Natasha Leighl; Amit Oza; Malcolm Moore; Anne Rydall; Gary Rodin; Ian Tannock; Allan Donner; Christopher Lo Journal: Lancet Date: 2014-02-19 Impact factor: 79.321
Authors: Jennifer W Mack; Angel Cronin; Nancy L Keating; Nathan Taback; Haiden A Huskamp; Jennifer L Malin; Craig C Earle; Jane C Weeks Journal: J Clin Oncol Date: 2012-11-13 Impact factor: 44.544
Authors: Craig C Earle; Mary Beth Landrum; Jeffrey M Souza; Bridget A Neville; Jane C Weeks; John Z Ayanian Journal: J Clin Oncol Date: 2008-08-10 Impact factor: 44.544
Authors: Amy P Abernethy; David C Currow; Tania Shelby-James; Debra Rowett; Frank May; Gregory P Samsa; Roger Hunt; Helena Williams; Adrian Esterman; Paddy A Phillips Journal: J Pain Symptom Manage Date: 2012-10-24 Impact factor: 3.612
Authors: Marie Bakitas; Kathleen Doyle Lyons; Mark T Hegel; Stefan Balan; Kathleen N Barnett; Frances C Brokaw; Ira R Byock; Jay G Hull; Zhongze Li; Elizabeth McKinstry; Janette L Seville; Tim A Ahles Journal: Palliat Support Care Date: 2009-03
Authors: Anna Sorensen; Kirsten Wentlandt; Lisa W Le; Nadia Swami; Breffni Hannon; Gary Rodin; Monika K Krzyzanowska; Camilla Zimmermann Journal: Support Care Cancer Date: 2019-06-04 Impact factor: 3.603
Authors: David Hui; Masanori Mori; Yee-Choon Meng; Sharon M Watanabe; Augusto Caraceni; Florian Strasser; Tiina Saarto; Nathan Cherny; Paul Glare; Stein Kaasa; Eduardo Bruera Journal: Support Care Cancer Date: 2017-07-19 Impact factor: 3.603
Authors: Emanuela Scarpi; Monia Dall'Agata; Vittorina Zagonel; Teresa Gamucci; Raffaella Bertè; Elisabetta Sansoni; Elena Amaducci; Chiara Maria Broglia; Sara Alquati; Ferdinando Garetto; Stefania Schiavon; Silvia Quadrini; Elena Orlandi; Andrea Casadei Gardini; Silvia Ruscelli; Daris Ferrari; Maria Simona Pino; Roberto Bortolussi; Federica Negri; Silvia Stragliotto; Filomena Narducci; Martina Valgiusti; Alberto Farolfi; Oriana Nanni; Romina Rossi; Marco Maltoni Journal: Support Care Cancer Date: 2018-10-24 Impact factor: 3.603
Authors: Julia Berendt; Stephanie Stiel; Steffen T Simon; Andrea Schmitz; Birgitt van Oorschot; Peter Stachura; Christoph Ostgathe Journal: Oncologist Date: 2016-07-20